Recruiting studies: Breast Cancer Infiltrating Ductal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Registry Study of Breast Microseed Treatment
Phase N/A · 3 location(s) · Concure Oncology-Breast Microseed Inc. · NCT02701244 Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NA · 1 location(s) · Innoblative Designs, Inc. · NCT07206121 Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
Phase 2 · 2 location(s) · Universität Münster · NCT06540872 Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Phase N/A · 1 location(s) · Oncoliq US Inc · NCT07331506 A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast
Phase 1 · 3 location(s) · Shanghai Jiao Tong University School of Medicine · NCT02897700 Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
Phase 2 · 4 location(s) · Legacy Health System · NCT07506876

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.